Literature DB >> 20177515

Care of the infant born to an HIV-positive mother.

.   

Abstract

Entities:  

Year:  2000        PMID： 20177515      PMCID： PMC2817774          DOI： 10.1093/pch/5.3.161

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  16 in total

1.  Should there be routine testing for human immunodeficiency virus infection in pregnancy?

Authors: 
Journal:  Can J Infect Dis       Date:  1994-09

2.  Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.

Authors:  S Taneepanichskul; S Sirinavin; W Phuapradit; K Chaturachinda
Journal:  Aust N Z J Obstet Gynaecol       Date:  1997-08       Impact factor: 2.100

3.  Evaluation and medical treatment of the HIV-exposed infant. American Academy of Pediatrics. Committee on Pediatric AIDS.

Authors: 
Journal:  Pediatrics       Date:  1997-06       Impact factor: 7.124

4.  Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.

Authors:  S A Fiscus; A A Adimora; V J Schoenbach; W Lim; R McKinney; D Rupar; J Kenny; C Woods; C Wilfert
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

5.  The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

Authors:  W Andiman; Y Bryson; M de Martino; M Fowler; D Harris; C Hutto; B Korber; A Kovacs; S Landesman; M Lindsay; N Lapointe; L Mandelbrot; M-L Newell; H Peavy; J Read; C Rudin; A Semprini; R Simonds; R Tuomala
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

6.  The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy.

Authors:  R B Van Dyke; B T Korber; E Popek; C Macken; S M Widmayer; A Bardeguez; I C Hanson; A Wiznia; K Luzuriaga; R R Viscarello; S Wolinsky
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

8.  Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

Authors:  D M Thea; G Lambert; J Weedon; P B Matheson; E J Abrams; M Bamji; W L Straus; P A Thomas; K Krasinski; M Heagarty
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

9.  1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-04-28

10.  Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Authors:  M Culnane; M Fowler; S S Lee; G McSherry; M Brady; K O'Donnell; L Mofenson; S L Gortmaker; D E Shapiro; G Scott; E Jimenez; E C Moore; C Diaz; P M Flynn; B Cunningham; J Oleske
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272
View more
  1 in total

1.  Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.